Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

E

ENGN

enGene Therapeutics Inc

1.80

Aug 04 • 10:47 AM ET +0.03 (1.81%)

Healthcare Biotechnology Canada Micro NASD

Peers: SANA KRYS BMRN INCY RYTM KYMR NUVL AXSM VKTX NBIX

Scroll to Statements

Index	-
Market Cap	120.71M
Enterprise Value	-104.48M
Income	-126.85M
Sales	0.00M
Book/sh	3.81
Cash/sh	3.86
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	82
IPO	Feb 01, 2022

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.47
P/C	0.47
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	12.57
Current Ratio	12.57
Debt/Eq	0.13
LT Debt/Eq	0.12
Option/Short	Yes / Yes

EPS (ttm)	-2.18
EPS next Y	-1.51
EPS next Q	-0.44
EPS this Y	22.87%
EPS next Y	14.46%
EPS next 5Y	24.37%
EPS past 3/5Y	- -255.92%
Sales past 3/5Y	- -
EPS Y/Y TTM	-32.34%
Sales Y/Y TTM	-
EPS Q/Q	14.33%
Sales Q/Q	-
Earnings	Jun 15 BMO
EPS/Sales Surpr.	7.76% -

Insider Own	63.41%
Insider Trans	0.00%
Inst Own	51.00%
Inst Trans	-5.04%
ROA	-44.19%
ROE	-52.58%
ROIC	-44.35%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-2.24%
SMA50	1.38%
SMA200	-71.49%
Trades

Shs Outstand	66.99M
Shs Float	24.51M
Short Float	6.69%
Short Ratio	0.86
Short Interest	1.64M
52W High	12.25 -85.29%
52W Low	1.40 28.71%
Volatility	5.23% 5.49%
ATR (14)	0.10
RSI (14)	44.55
Beta	-0.28
Rel Volume	0.61
Avg Volume	1.91M
Volume	277,157

Perf Week	2.39%
Perf Month	-5.65%
Perf Quarter	-76.32%
Perf Half Y	-81.98%
Perf YTD	-80.04%
Perf Year	-52.83%
Perf 3Y	-83.28%
Perf 5Y	-
Perf 10Y	-
Recom	2.55
Target Price	3.50
Prev Close	1.77
Price	1.80
Change	1.81%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)